Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|February 1, 1997
Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniaeK S Thomson, S A Chartrand, C C Sanders, et al.
The Journal of Rheumatology|April 1, 2000
Clinical efficacy of mesalamine in the treatment of the spondyloarthropathiesG T Thomson, B R Thomson, K S Thomson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1990
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinationsK S Thomson, D A Weber, C C Sanders, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 2001
Activity of faropenem against resistant isolates of Streptococcus pneumoniaeJ A Black, E S Moland, S A Chartrand, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1984
3-Dimensional susceptibility testing of beta-lactam antibioticsK S Thomson, Z A Mejglo, G N Pearce, et al.
Science (New York, N.Y.)|July 29, 1994
A devonian tetrapod from north americaE B Daeschler, N H Shubin, K S Thomson, et al.
Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology|April 18, 1998
[Evaluation of the E-test: comparison of E-test and microbroth dilution method in azole antifungal susceptibility test]H Komaki, Y Tanaka, K Yazawa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1993
Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatinA F Ehrhardt, C C Sanders, K S Thomson, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacinA Pong, K S Thomson, E S Moland, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Beta-lactamases and detection of beta-lactam resistance in Enterobacter sppJ D Pitout, E S Moland, C C Sanders, et al.
Pageof 6